Accelerated discovery of novel targeted protein degradation therapeutics
As targeted protein degradation continues to evolve as a new therapeutic modality, specialist computational approaches can provide deep insights to ...
Cambridge, UK – March 29th, 2022 – Cresset Discovery, provider of CADD expertise for drug discovery, is collaborating with the Translation team at The Francis Crick Institute as expert computational chemist in residence.
Computational chemistry is a powerful method in tool development and drug discovery. It enables chemists to predict the physical properties and biological activity of compounds prior to synthesis and analysis, saving significant time and money by removing unnecessary wet chemistry.
“Having access to the computational chemistry team at Cresset Discovery will enhance our ability to develop tools to validate biological target hypothesis,” says Dr Veronique Birault, Director of Translation, The Crick. “We chose to work with Cresset Discovery for their expertise and as the contract offers us interaction on an ad hoc basis to evaluate unprecedent biological targets.”
“We have been in active discussions together with the Translation team and scientists at The Crick for some time now, primarily providing consultation on the potential for applying innovative in silico techniques to complement a range of exciting projects. This new agreement allows a flexible, fee-for-service model, the Translation team at the Crick can draw down time as and when it is required,” says Dr Martin Slater, Director of Consulting at Cresset Discovery.